Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
AnPac Bio-Medical Science Announces Signing of US$5.2 Million of Definitive Investment Agreements
January 25, 2023 08:30 ET
|
ANPAC BIO-MEDICAL SCIENCE CO., LTD.
New York, NY, Jan. 25, 2023 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (the “Company”) (Nasdaq: ANPC), a biotechnology company with operations in the United States and China focused on...
AnPac Bio-Medical Sciences Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request A Hearing
January 20, 2023 16:30 ET
|
ANPAC BIO-MEDICAL SCIENCE CO., LTD.
New York, NY, Jan. 20, 2023 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (the “Company”) (Nasdaq: ANPC), a biotechnology company with operations in the United States and China focused on...
ProPhase Labs to Present at The ThinkEquity Conference
October 18, 2022 08:00 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Oct. 18, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced it will be...
Nebula Genomics Strengthens Advisory Board with Appointment of Russ Altman, M.D., Ph.D.
October 17, 2022 08:00 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Oct. 17, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth-oriented and diversified diagnostics, genomics and biotech company, today announced that its wholly...
Chemiluminescence Immunoassay Market Size is projected to reach USD 12.73 Billion by 2030, growing at a CAGR of 7.5%: Straits Research
September 07, 2022 12:50 ET
|
Straits Research
New York, United States, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Chemiluminescence immunoassay (CLIA) is an immunological technique used for the detection and monitoring of chronic disorders. The...
ProPhase Labs to Present at the MicroCap Rodeo Winter Wonderland Best Ideas Virtual Conference
February 03, 2022 08:30 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Feb. 03, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at...
ProPhase Labs to Present at Two Upcoming August Conferences
August 16, 2021 08:30 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Aug. 16, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, today announced that Chairman and CEO Ted Karkus is scheduled to...
ProPhase Labs to Host Second Quarter 2021 Financial Results Conference Call on Friday, August 13, 2021 at 11:00 a.m. Eastern Time
August 09, 2021 08:30 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY , Aug. 09, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, will hold a conference call on Friday, August 13, 2021...
Fuisz Pharma Announces Receipt of a Notice of Patent Allowance for Breath Diagnostics; The Invention addresses the Issue of Ambient Contaminants that Skew Results
June 22, 2021 08:00 ET
|
FUISZ LLC
Franklin, TN, June 22, 2021 (GLOBE NEWSWIRE) -- Fuisz Pharma LLC (Fuisz Pharma) today announced its receipt from the United States Patent and Trademark Office (PTO) of a notice of allowance for App....
ProPhase Labs to Present at the Virtual Fall Investor Summit on Monday, November 16, 2020 at 2:30 p.m. Eastern Time
November 10, 2020 08:30 ET
|
ProPhase Labs, Inc.
DOYLESTOWN, PA , Nov. 10, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase Labs”), a diversified medical science and technology company, today announced that management will...